title: Prophylactic migraine therapy: emerging treatment options.
abstract: In this paper, new treatment options for migraine prevention are reviewed. An overview about migraine pathophysiology is provided and current indications for migraine prevention and new and upcoming preventive medications are discussed briefly. Data are presented on topiramate, levetiracetam, zonisamide, botulinim toxin, tizanidine, nefazodone, lisinopril, candesartan, carabersat, petasites, and coenzyme Q.
authors.affiliation: Department of Neurology, Albert Einstein College of Medicine, 1165 Morris Park Avenue, Bronx, NY 10461, USA. mbigal@aecom.yu.edu
authors.forename: Marcelo E
authors.initials: ME
authors.lastname: Bigal
authors.forename: Abouch V
authors.initials: AV
authors.lastname: Krymchantowski
authors.forename: Alan M
authors.initials: AM
authors.lastname: Rapoport
mesh_terms: D002491:Central Nervous System Agents / Q000627:therapeutic use*; D006801:Humans; D008881:Migraine Disorders / Q000503:physiopathology / Q000517:prevention & control*; D020011:Protective Agents / Q000627:therapeutic use*
chemical_list: D002491:Central Nervous System Agents; D020011:Protective Agents